📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Novel epigenetic therapies in hematological malignancies: Current status and beyond (2018)

First Author: Gallipoli P

Attributed to: Characterising and targeting aberrant enhancer function in acute myeloid leukaemia (AML) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.17863/cam.12327

Publication URI: https://www.repository.cam.ac.uk/handle/1810/267479

Type: Journal Article/Review